Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells
Jennifer Yang(AstraZeneca (Poland)), Gregory B. Lesinski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 52
Related Papers
Microfluidic, marker-free isolation of circulating tumor cells from blood samples
|Nature Protocols|2014|753
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
|Gut|2016|540
Monolithic Chip for High-throughput Blood Cell Depletion to Sort Rare Circulating Tumor Cells
|Scientific Reports|2017|171
The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse
|Journal of Clinical Investigation|2003|140